Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of 20230930-DK-Butterfly-1, Inc. from 27 Feb 2016 to 25 Feb 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
20230930-DK-Butterfly-1, Inc. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD history and change rate from 27 Feb 2016 to 25 Feb 2023.
  • 20230930-DK-Butterfly-1, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 25 Feb 2023 was $147,357,000, a 69% decline year-over-year.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

20230930-DK-Butterfly-1, Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $147,357,000 -$323,527,000 -69% 25 Feb 2023 10-K 14 Jun 2023 2022 FY
Q4 2022 $225,659,000 -$314,782,000 -58% 26 Nov 2022 10-Q 26 Jan 2023 2022 Q3
Q3 2022 $166,716,000 -$858,114,000 -84% 27 Aug 2022 10-Q 30 Sep 2022 2022 Q2
Q2 2022 $138,931,000 -$994,723,000 -88% 28 May 2022 10-Q 29 Jun 2022 2022 Q1
Q1 2022 $470,884,000 -$936,340,000 -67% 26 Feb 2022 10-K 14 Jun 2023 2022 FY
Q4 2021 $540,441,000 -$953,766,000 -64% 27 Nov 2021 10-Q 26 Jan 2023 2022 Q3
Q3 2021 $1,024,830,000 -$451,257,000 -31% 28 Aug 2021 10-Q 30 Sep 2022 2022 Q2
Q2 2021 $1,133,654,000 -$21,500,000 -1.9% 29 May 2021 10-Q 29 Jun 2022 2022 Q1
Q1 2021 $1,407,224,000 +$383,574,000 +37% 27 Feb 2021 10-K 14 Jun 2023 2022 FY
Q4 2020 $1,494,207,000 +$570,820,000 +62% 28 Nov 2020 10-Q 06 Jan 2022 2021 Q3
Q3 2020 $1,476,087,000 +$468,930,000 +47% 29 Aug 2020 10-Q 30 Sep 2021 2021 Q2
Q2 2020 $1,155,154,000 +$422,955,000 +58% 30 May 2020 10-Q 30 Jun 2021 2021 Q1
Q1 2020 $1,023,650,000 +$493,679,000 +93% 29 Feb 2020 10-K 14 Jun 2023 2022 FY
Q4 2019 $923,387,000 +$139,874,000 +18% 30 Nov 2019 10-Q 07 Jan 2021 2020 Q3
Q3 2019 $1,007,157,000 +$116,860,000 +13% 31 Aug 2019 10-Q 01 Oct 2020 2020 Q2
Q2 2019 $732,199,000 +$32,553,000 +4.7% 01 Jun 2019 10-Q 08 Jul 2020 2020 Q1
Q1 2019 $529,971,000 +$162,831,000 +44% 02 Mar 2019 10-K 21 Apr 2022 2021 FY
Q4 2018 $783,513,000 01 Dec 2018 10-Q 09 Jan 2020 2019 Q3
Q3 2018 $890,297,000 01 Sep 2018 10-Q/A 15 Oct 2019 2019 Q2
Q2 2018 $699,646,000 02 Jun 2018 10-Q 11 Jul 2019 2019 Q1
Q1 2018 $367,140,000 -$142,189,000 -28% 03 Mar 2018 10-K 22 Apr 2021 2020 FY
Q1 2017 $509,329,000 -$27,244,000 -5.1% 25 Feb 2017 10-K 29 Apr 2020 2019 FY
Q1 2016 $536,573,000 27 Feb 2016 10-K 30 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.